Glaukos (GKOS) EBT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 17.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.38% |
| Dec 31, 2025 | -6.24% |
| Sep 30, 2025 | 16.35% |
| Jun 30, 2025 | 24.80% |
| Mar 31, 2025 | -72.41% |
| Dec 31, 2024 | 88.42% |
| Sep 30, 2024 | -74.36% |
| Jun 30, 2024 | -42.72% |
| Mar 31, 2024 | -35.71% |
| Dec 31, 2023 | 110.34% |
| Sep 30, 2023 | -22.26% |
| Jun 30, 2023 | 11.86% |
| Mar 31, 2023 | 14.37% |
| Dec 31, 2022 | 63.53% |
| Sep 30, 2022 | -27.07% |
| Jun 30, 2022 | -94.15% |
| Mar 31, 2022 | 88.28% |
| Dec 31, 2021 | -132.33% |
| Sep 30, 2021 | 43.85% |
| Jun 30, 2021 | -47.46% |
| Mar 31, 2021 | -81.54% |
| Dec 31, 2020 | -153.73% |
| Sep 30, 2020 | -141.43% |
| Jun 30, 2020 | -143.39% |
| Mar 31, 2020 | -292.40% |
| Dec 31, 2019 | -80.15% |
| Sep 30, 2019 | -130.54% |
| Jun 30, 2019 | -67.20% |
| Mar 31, 2019 | -49.78% |
| Dec 31, 2018 | -59.40% |
| Sep 30, 2018 | -47.37% |
| Jun 30, 2018 | 45.08% |
| Mar 31, 2018 | -22.78% |
| Dec 31, 2017 | 30.53% |
| Sep 30, 2017 | 39.26% |
| Jun 30, 2017 | -9.55% |
| Mar 31, 2017 | 30.68% |